Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Thermostability is a critical factor in ensuring equitable access to effective mRNA vaccines in LMICs.
“Thermostability is another critical factor in ensuring equitable access to effective mRNA vaccines in LMICs42.”
From An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial (2024) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 11 · Cited by 128
- Authors
- Figueroa, J. P., Bottazzi, M. E., Hotez, P., Batista, C., Ergonul, O., Gilbert, S., Gursel, M., Hassanain, M., Kim, J. H., Lall, B., Larson, H., Naniche, D., Sheahan, T., Shoham, S., Wilder-Smith, A., Strub-Wourgaft, N., Yadav, P., & Kang, G.
- Corresponding author
- Figueroa, J Peter
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 397
- Issue
- 10274
- Pages
- 562-564
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7906712
- OpenAlex
- W3125678323
- Cited by
- 128
- References
- 11
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 12 · 2023: 18 · 2022: 38 · 2021: 49 · 2014: 1 · 2013: 1
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OpenMETU (Middle East Technical University) (submittedVersion, cc-by-nc-nd)
- Funders
- UK Research and Innovation (ES/P010873/1, ES/P010873)
- Global Challenges Research Fund (ES/P010873/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Legal, Health, Environmental and COVID-19 Challenges
- Keywords
- COVID-19 vaccines, COVID-19 treatment, low-income countries, middle-income countries, equitable access, vaccine distribution, global health equity
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, COVID-19 Testing, Developing Countries, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
